Autonomic Nervous System Diseases - Drug therapy
Research News and Information

Sunday, November 22, 2009

Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy.

7 Jun 2009 OBJECTIVE: To evaluate the efficacy of immunotherapy in the treatment of patients with seropositive and seronegative putative autoimmune autonomic ganglionopathy (AAG) using validated autonomic function tests and instruments. BACKGROUND: AAG is an ... Read more...

[Interest of Ineurope syringe for nerve agent intoxication]

3 Apr 2009 Chemical weapons represent an ever-growing threat, not only for military forces but also for civilian populations. Nerve agents such as those used in terrorist attacks by the Aum sect in Tokyo are among the deadliest of those non conventional ... Read more...

Sympathetic hyperactivity and clinical outcome in chronic kidney disease patients during standard treatment.

27 Feb 2009 BACKGROUND: Sympathetic hyperactivity has been associated with adverse clinical outcome and is common in patients with chronic kidney disease (CKD). Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) have been ... Read more...

Latest indexed articles for 'Autonomic Nervous System Diseases - Drug therapy'

These are the very latest articles for this heading:

• Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy. 7 Jun 2009
• Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the american academy of neurology. 12 Apr 2009
• [Interest of Ineurope syringe for nerve agent intoxication] 3 Apr 2009
• Sympathetic hyperactivity and clinical outcome in chronic kidney disease patients during standard treatment. 27 Feb 2009
• Peripheral autoimmune neuropathy assessed using corneal in vivo confocal microscopy. 27 Feb 2009
• Treatment of early Parkinson's disease. Part 2. 27 Jan 2009
• Successful treatment for sympathetic storms in a patient with neuro-Behçet's disease. 18 Dec 2008
• Correction of severe hypotension by oral pseudoephedrine in a patient with idiopathic autonomic dysfunction. 30 Aug 2008
• Intravenous magnesium sulphate infusion in the management of very severe tetanus in a child: a descriptive case report. 10 Aug 2008
• Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. 9 Jul 2008
• Therapeutic uses of botulinum toxin: from facial palsy to autonomic disorders. 30 May 2008
• Invited Article: Autonomic ganglia: target and novel therapeutic tool. 11 May 2008
• Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. 4 May 2008
• Re: Combined therapy with carvedilol and amiodarone is more effective in improving cardiac symptoms, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with carvedilol therapy alone. 21 Apr 2008
• [Effect of a complex treatment, including glutargin and erbisol on the blood plasma content of protein P53, apoptotic markers of type II, activity of caspases and the level of sCD 117 in patients with autonomic-vascular dystonia] 30 Mar 2008
• L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience. 25 Mar 2008
• L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience. 25 Mar 2008
• The use of botulinum toxin in head and face medicine: an interdisciplinary field. 8 Mar 2008
• Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy. 30 Jan 2008
• Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing: response to antiepileptic dual therapy. 30 Dec 2007

See a longer list of these articles.

Technical information about 'Autonomic Nervous System Diseases'

Definition: Diseases of the parasympathetic or sympathetic divisions of the AUTONOMIC NERVOUS SYSTEM; which has components located in the CENTRAL NERVOUS SYSTEM and PERIPHERAL NERVOUS SYSTEM. Autonomic dysfunction may be associated with HYPOTHALAMIC DISEASES; BRAIN STEM disorders; SPINAL CORD DISEASES; and PERIPHERAL NERVOUS SYSTEM DISEASES. Manifestations include impairments of vegetative functions including the maintenance of BLOOD PRESSURE; HEART RATE; pupil function; SWEATING; REPRODUCTIVE AND URINARY PHYSIOLOGY; and DIGESTION.

Descriptor UI: D001342

Alternative terms: Autonomic Nervous System Diseases; ANS Diseases; ANS Disease; Nervous System Diseases, Autonomic; Autonomic Nervous System Disorders; Central Autonomic Nervous System Diseases; Disorders of the Autonomic Nervous System; ANS (Autonomic Nervous System) Diseases; Autonomic Diseases; Autonomic Disease; Peripheral Autonomic Nervous System Diseases; Autonomic Peripheral Nervous System Diseases; Nervous System Diseases, Sympathetic; Sympathetic Nervous System Diseases; Segmental Autonomic Dysfunction; Autonomic Dysfunction, Segmental; Autonomic Dysfunctions, Segmental; Segmental Autonomic Dysfunctions; Autonomic Central Nervous System Diseases; Nervous System Diseases, Parasympathetic; Parasympathetic Nervous System Diseases;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C10.177;

History Note: 1981; was AUTONOMIC SYSTEM DISEASES (NON MESH) before 1981